Prostate Cancer Diagnosis: New Application of Genomic Tests Presented

Prostate Cancer Diagnosis: New Application of Genomic Tests Presented
0
(0)

Investigators in the field of prostate cancer are always looking for ways to increase understanding about the disease, as well as improve diagnosis and treatment. Dr. Jeffrey Tomaszewski, an assistant professor at the Department of Surgery of the MD Anderson Cancer Center at Cooper Medical School of Rowan University is among them.

Dr. Tomaszewski was present at the 2016 American Urological Association Anual Meeting to present a new application of prostate cancer genomic tests. The physician is specialized in urological oncology, which includes prostate cancer and he discusses the use of common genomic biomarkers in different phases of prostate cancer screening, diagnosis, and treatment.

In this video, Dr. Tomaszewski explains that his research is focused on the use of either sample tissue or tissue from a resected prostate cancer to analyze the genetic mutation that caused the development of prostate cancer. Given the recent use of genomic biomarkers in the field, the physician advocates for the increase of information about it in order to improve prostate cancer diagnosis and treatment.

Learn more about prostate cancer.

Prostate Cancer News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

For those with Prostate Cancer, participating in clinical trials provides access to experimental therapies and helps advance science toward a cure for the disease. Visit this link  to get more information about Prostate Cancer clinical trials in your area.
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
×
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
Latest Posts
  • NCCN and Rubraca
  • Orgovyx and FDA approval
  • Lynparza
  • Erleada results

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *